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The mitochondrial tRNA genes are hot spots for mutations
that lead to human disease. A single pointmutation (T4409C) in
the gene for human mitochondrial tRNAMet (hmtRNAMet) has
been found to cause mitochondrial myopathy. This mutation
results in the replacement of U8 in hmtRNAMet with a C8. The
hmtRNAMet serves both in translational initiation and elonga-
tion in human mitochondria making this tRNA of particular
interest in mitochondrial protein synthesis. Here we show that
the single 8U3C mutation leads to a failure of the tRNA to
respond conformationally to Mg2. This mutation results in a
drastic disruption of the structure of the hmtRNAMet, which
significantly reduces its aminoacylation. The small fraction of
hmtRNAMet that can be aminoacylated is not formylated by the
mitochondrial Met-tRNA transformylase preventing its func-
tion in initiation, and it is unable to form a stable ternary com-
plex with elongation factor EF-Tu preventing any participation
in chain elongation. We have used structural probing and
molecular reconstitution experiments to examine the structures
formed by the normal and mutated tRNAs. In the presence of
Mg2, the normal tRNA displays the structural features
expected of a tRNA.However, even in the presence ofMg2, the
mutated tRNA does not form the cloverleaf structure typical of
tRNAs. Thus, we believe that this mutation has disrupted a crit-
ical Mg2-binding site on the tRNA required for formation of
the biologically active structure. This work establishes a foun-
dation for understanding the physiological consequences of the
numerous mitochondrial tRNAmutations that result in disease
in humans.
Human mitochondria are subcellular organelles that pro-
duce more than 90% of the energy required by the cell. The
mitochondrial genome encodes 13 proteins necessary for
energy production, two rRNAs and all of the 22 tRNAs required
for the synthesis of these proteins (1, 2).Mammalianmitochon-
drial tRNAs have several unusual features that distinguish them
fromcanonical tRNAs. Inmany cases, they lack a number of the
conserved or semi-conserved nucleotides that play important
roles in creating the L-shaped tertiary structure of prokaryotic
and eukaryotic cytoplasmic tRNAs (3). There is little detailed
structural information on these tRNAs. No data are currently
available that examine the structure of mammalian mitochon-
drial tRNAs with single nucleotide resolution. However, chem-
ical and enzymatic probing has lead to the idea that these
tRNAs have retained the basic cloverleaf structure of canonical
tRNAs but that they lack several conserved tertiary interactions
leading to a weaker three-dimensional structure (4–8). In par-
ticular, a number of the long range interactions between the D-
and T-arms of the tRNAs appear to be missing.
All 22 tRNAs that function in mammalian mitochondria are
encoded in the mitochondrial DNA. Considerable interest in
mitochondrial tRNAs centers on the occurrence of diseases
arising from mutations in their genes that lead to maternally
inherited genetic disorders (9–12). The diseases associated
with mitochondrial tRNA mutations may arise from failure in
the processing of the tRNA (13), from reduced stability of the
tRNA (14, 15), from a reduction in aminoacylation (12, 16, 17),
froma reduced ability of themutated aminoacyl-tRNA to inter-
act with mitochondrial elongation factor Tu (EF-Tumt)3 (the
corresponding prokaryotic factor is also designated EF1A) (16),
and from the failure of the tRNA to be correctly modified lead-
ing to translational defects (18).
Normally, protein biosynthetic systems have two tRNAMet
species.One is used solely for initiation, and the other functions
in polypeptide chain elongation. Animal mitochondria are
quite unusual in that they contain a single gene for tRNAMet,
which functions in both polypeptide chain initiation and chain
elongation. As a result of this dual role, mitochondrial Met-
tRNAMet must be recognized by the mitochondrial Met-tRNA
transformylase (MTFmt) and be brought as fMet-tRNAMet to
the ribosome for translational initiation (19). In addition,
Met-tRNAMet must interact with elongation factor EF-Tumt
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and bind to the A-site of the ribosome during translational
elongation. Thus, this tRNAMet is of central importance in
mitochondrial translation.
Human tRNAMet has a number of interesting features (Fig.
1A). The D-loop is somewhat small and lacks the G residues at
positions 18 and 19 that facilitate interactions with the T-loop
in the tertiary structure. The first position of the anticodon
contains the rare modified base 5-formylcytidine. This modifi-
cation may play a role in the unusual codon recognition
requirements of this tRNA, which must recognize both AUG
and AUA codons. The minor loop is short lacking the usual
G47, and the T-stem has two adjacent pyrimidine:pyrimidine
pairs (U-U and U-). Furthermore, the T-loop lacks the TC
sequence and contains only six nucleotides instead of the nor-
mal seven. These unusual structural features suggest that
human mitochondrial tRNAMet may have an intrinsically weak
tertiary structure.
Three interesting point mutations (T4409C, A4435G, and
G4450A) occur in the gene for human tRNAMet (hmtRNAMet).
The T4409C mutation (Fig. 1A) results in a U8 to C change at
the corner of the acceptor stem and D-stem of hmtRNAMet.
This mutation leads to mitochondrial myopathy resulting in
dystrophic muscles and exercise intolerance (20). The A4435G
mutation leads to the change of A37 to G37 in the anticodon
loop of the tRNA (21). This mutation acts as a modulator of
Leber’s Hereditary Optic Neuropathy increasing the severity of
this condition when it arises because of other mutations in the
mitochondrial DNA. The G4450Amutation leads to loss of the
final base pair in the T-stem (Fig. 1A). This mutation presents
as splenic lymphoma, is largely confined to lymphocyte cells,
and results in severely abnormal mitochondria leading to seri-
ous defects in energy production (22). A systematic examina-
tion of the structural and biochemical consequences of these
mutations is lacking. Here we examine the structure of human
mitochondrial tRNAMet and probe the effects of the 8U3C
mutation on the structure and function of this tRNA.
EXPERIMENTAL PROCEDURES
RNA Synthesis—Human mitochondrial tRNAMet transcripts
for aminoacylation experiments were prepared by in vitro tran-
scription using the hammerhead ribozyme construct described
previously (23). The hmtRNAMet was purified by denaturing
(10%) PAGE (29:1 acrylamide:bisacrylamide prepared with 7 M
urea, 90 mM Tris borate, 2 mM EDTA), visualized by UV shad-
owing, excised from the gel, and recovered by passive elution in
water followed by ethanol precipitation. hmtRNAMet tran-
scripts for selective 2-hydroxyl acylation analyzed by primer
extension (SHAPE) experiments were prepared in the context
of the structure cassette as described (24). D- and T-half-mol-
ecules were chemically synthesized (Dharmacon), purified, and
analyzed as described previously (25).
Purification of E. coli Methionyl-tRNA Synthetase (MetRS)
and Human Mitochondrial MetRS (hmMetRS)—A saturated
overnight culture of JM109 cells carrying the pQE60-Esche-
richia coli MetRS plasmid construct (kindly provided by
Uttam RajBhandary, Massachusetts Institute of Technology)
was grown at 37 °C in 2 YT media (20 ml) supplemented
with 50 g/ml ampicillin and used to inoculate 2 liters of 2
YT media (50 g/ml ampicillin). The cells were grown at
37 °C for 4 h (A600  0.6), induced with 50 M isopropyl
-D-thiogalactopyranoside and then grown at 37 °C for 4 h
post-induction. The cells were harvested by centrifugation at
4,000 rpm for 30 min. The cell pellet was resuspended in 500
ml of 10 mM Tris-HCl, pH 7.6, and then re-collected by low
speed centrifugation. The cell pellet was fast frozen and
stored at 80 °C until use.
The cell pellet (7 g) was resuspended in 100 ml of lysis buffer
(50 mM Tris-HCl, pH 7.6, 50 mM KCl, 10 mM MgCl2, 200 M
phenylmethylsulfonyl fluoride (PMSF), 0.1% Triton X-100, and
7 mM -mercaptoethanol (ME)) and sonicated on ice for 7
min with 10-s bursts followed by 50-s cooling periods. The cell
lysate was centrifuged at 15,000 rpm for 30 min at 4 °C. E. coli
MetRS was purified from the supernatant using 400 l of a 50%
nickel-nitrilotriacetic acid (Qiagen) slurry in wash buffer (100
mMTris-HCl, pH 7.6, 1 M KCl, 10mMMgCl2, 10mM imidazole,
200 M PMSF, and 7mM ME). The resin was washed with 200
ml of wash buffer. The protein was eluted with 4 ml of elution
buffer (100 mM Tris-HCl, pH 7.6, 50 mM KCl, 10 mM MgCl2,
150mM imidazole, 200MPMSF, and 7mM ME). The protein
sample was dialyzed against 2 volumes of 500 ml of dialysis
buffer (50 mM Tris-HCl, pH 7.6, 50 mMKCl, 2.5 mMMgCl2, 0.1
mM EDTA, 10% glycerol and 7 mM ME) for 1 h.
Cells carrying a plasmid encoding the His6-tagged human
mitochondrial MetRS were grown as described (23). The cells
were lysed as described above, and the hmMetRS was further
purified as described (23).
Purification of Bovine Mitochondrial Methionyl-tRNA
Transformylase (MTFmt)—E. coli BL21 cells, carrying the
pET15-bovine MTFmt plasmid construct, were grown as
described (19). Cells were harvested and lysed as described for
E. coliMetRS above. The protein was purified as described for
the E. coliMetRS except that the buffers contained 50mMTris-
HCl, pH 7.6. The purified protein sample was dialyzed against 2
volumes of 500 ml of MTF dialysis buffer (20 mM Tris-HCl, pH
7.6, 100 mM KCl, 10% glycerol, and 3 mM ME) for 1 h, fast-
frozen, and stored at 80 °C.
Assay for the Aminoacylation of Human Mitochondrial
tRNAMet—The aminoacylation reactions for both the normal
and 8U3C mutated tRNAMet transcripts were performed
essentially as described (23). Reaction mixtures (100 l) con-
tained 50mMTris-HCl, pH 7.6, 2.5mMMgCl2, 2.5mMATP, 0.2
mM spermine, 200 g/ml bovine serum albumin, 0.2 units/l
SUPERaseIn RNase inhibitor, 40 M [35S]methionine (4,000
cpm/pmol), 50 nM humanmitochondrial MetRS or 8 nM E. coli
MetRS, and 1 M U8 or 8U3C hmtRNAMet. The amount of
aminoacylated tRNA formed was determined by trichloroace-
tic acid-precipitable counts at the indicated times.
Preparative Aminoacylation of [35S]Met-tRNAMet—Reaction
mixtures (2 ml) were prepared as described above except that
20 M [35S]methionine (20,000 cpm/pmol), 0.5 M U8, or
8U3C hmtRNAMet, and saturating amounts of human mito-
chondrial MetRS were used. Reactions were incubated for 15
min at 37 °C, followed by phenol/chloroform extraction. The
tRNAMet was collected by ethanol precipitation and then dis-
solved in 10 mM potassium succinate, pH 6.0, before use.
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Formylation of Human Mitochondrial Met-tRNAMet—
Formylation reactions (5 l) contained 20 mM Tris-HCl, pH
7.6, 100M EDTA, 150mMKCl, 7mMMgCl2, 10mM ME, 125
M folinic acid (Sigma), 100 nM normal or 8U3C mutated
[35S]Met-hmtRNAMet and 8 nM MTFmt. Reactions were per-
formed at 37 °C for 0–8min (0-min time point was taken in the
absence of enzyme). At the indicated time, 83 mM NaOH (1 l
of 500 mM) was added, and incubation was continued at 37 °C
for 30 min. The [35S]Met and [35S]fMet in 5 l of each reaction
were separated on Partisil LK5D TLC plates (Whatman) with a
butanol:acetic acid:water (4:1:1)mixture. TLC plates were visu-
alized by phosphorimaging (GEHealthcare) and the spots were
analyzed using the ImageQuant program.
Binding of Human Mitochondrial Met-tRNAMet to Bovine
Mitochondrial EF-Tu (EF-Tumt)—EF-Tumt was prepared as
described (26), except that the cells were lysed as described
above for E. coliMetRS, and the high speed centrifugation step
was omitted. Where indicated the normal U8 or 8U3C
mutated hmtRNAs were phosphorylated with cold ATP using
polynucleotide kinase (New England Biolabs) prior to large
scale aminoacylation.
To measure ternary complex formation, reaction mixtures
(50 l) were prepared as reported (27) except that 20 mM
Hepes-KOH, pH 7, and the indicated amounts of EF-Tumt were
used. The reactions were incubated for 15 min at 0 °C or 6 min
at 37 °C as indicated. Free [35S]Met-hmtRNAMet was digested
by a 30-s incubation with 10 g of RNase A, and the reaction
was terminated by the addition of cold 5% trichloroacetic
acid. Following a 10-min incubation on ice, the [35S]Met-
hmtRNAMet precipitate was collected on nitrocellulose filters
and quantified by liquid scintillation counting. Determination
of the Kd for ternary complex formation was carried out as
described previously (28).
Degradation of hmtRNAMet in aMitochondrial Extract—Bo-
vine mitoplasts (0.2 g) were prepared as described (29). Mito-
plasts were lysed in buffer (2 ml) containing 15 mM Tris-HCl,
pH7.6, 40mMKCl, 6mMMgCl2, 6mM ME, 0.8mMEDTA, and
1.6% Triton X-100 by hand homogenization. The extract was
clarified by centrifugation at 10,000 rpm for 15 min at 4 °C.
Normal U8 and 8U3C mutated hmtRNAMet were 32P-end-
labeled using polynucleotide kinase (New England Biolabs)
according to the manufacturer’s instructions. Reaction mix-
tures (10 l) contained 100 nM normal U8 or 8U3C mutated
[32P]hmtRNAMet and the indicated amount of the extract in the
lysis buffer above. Incubation was for 10 min at 37 °C, and cold
trichloroacetic acid precipitation was used to quantitate the
amount of [32P]hmtRNAMet remaining.
Selective 2-Hydroxyl Acylation Analyzed by Primer Exten-
sion (SHAPE) Analysis of Normal U8 and 8U3C Mutated
hmtRNAMet Transcripts—Normal U8 or 8U3C mutated
hmtRNAMet (12 pmol, 0.33 M) in 36 l of nuclease-free water
(Ambion) was incubated at 50 °C for 2 min and then cooled on
ice for 2min. The RNAwas divided into 2 aliquots of 4 pmol (12
l) and 8 pmol (24 l). Folding buffer (6 l; 333 mM Hepes-
KOH, pH8, 333mMNaCl)was added to the 4 pmol of RNA, and
folding bufferwith 20mMMg2 (12l) was added to the 8 pmol
of RNA, and the two samples were incubated at 37 °C for 20
min. To 1 l of 100 mM 1-methyl-7-nitroisotoic anhydride
(1M7) in anhydrous DMSO or 1 l of anhydrous DMSO (con-
trol), 9 l (2 pmol) of folded RNA was added and allowed to
react at 37 °C for 70 s (5 half-lives). The balance of the RNA
folded in the presence of Mg2 (18 l) was divided into 2 ali-
quots of 2 pmol (9 l) each and stored at 37 °C for sequencing.
MgCl2 (1 l; 64 mM) was added to the RNA treated with the
folding buffer in the absence of Mg2. Radiolabeled oligonu-
cleotide (0.3 M; 3 l; 5-32P-GAACCGGACCGAAGCCCG,
obtained from the Nucleic Acids Core Facility at University of
NorthCarolina)was added to the 1M7-treated,DMSO-treated,
or untreated RNA (2 pmol), and the samples were incubated at
65 °C for 5 min and then at 35 °C for 20 min for primer anneal-
ing. To each reaction, reverse transcription buffer (6l; 250mM
KCl, 167 mM Tris-HCl, pH 8.3, 17 mM dithiothreitol, and 0.42
mM each dNTP) was added. Then either ddCTP or ddTTP (1
l; 5 mM; Amersham Biosciences) was added to the untreated
RNA. After heating to 52 °C, reverse transcriptase (1 l; 200
units; Superscript III, Invitrogen) was added, and the primer
extension reactions were performed at 52 °C for 5 min. Reac-
tions were quenched with 4 M NaOH (1 l) and heated at 95 °C
for 5min. For gel analysis, a gel loading solution (29 l; 138mM
unbuffered Tris-HCl, 73% (v/v) formamide, 2 mM Tris borate,
86 mM EDTA, pH 8, with xylene cyanol and bromphenol blue)
was added, and the samples were heated at 95 °C for an addi-
tional 5 min. The cDNA products from the  and  1M7 and
sequencing reactions were separated by denaturing gel electro-
phoresis (10% polyacrylamide). Samples on gels (21 cm  40
cm  0.4 mm) were subjected to electrophoresis at 1400 V for
2.5 h. Gels were visualized by phosphorimaging (GE Health-
care). The and 1M7 band intensities were quantified using
SAFA (30) and corrected for signal drop-off (31). SHAPE reac-
tivities were normalized by subtracting intensities for the
1M7 control from the 1M7 reaction and dividing each by
the average reactivity of themost reactive 7%of the nucleotides.
To facilitate comparison of the normal U8 and 8U3C mutant
tRNAs, the two data sets were normalized to the reactivity
of the -CCA end nucleotides. The reactivity of each nucleotide
was assigned a value between 0 and 1. Nucleotides fall into one
of four categories (32, 33) as follows: unreactive (0.000–0.055),
low reactivity (0.055–0.110), moderately reactive (0.110–
0.220), or highly reactive (0.220–1.000).
Structural Studies of hmtRNAMet Half-molecules—Reconsti-
tution of hmtRNAMet from U8 and 8U3C D-half-molecules
with T-half-molecules required Mg2 and was assessed by gel
mobility shift assays using native 15% PAGE in Tris borate
buffer (89 mM Tris base, 89 mM boric acid, pH 8.3) with and
without 3 mM Mg2 at 4 °C (25). The concentration of the
D-half-molecule was held constant at 31.2 M, whereas the
concentration of the T-half-molecule was varied from 4.2 to
112 M.
UV-Monitored Thermodynamic Experiments—The half-
molecule RNA samples were dissolved in the above Tris borate
buffer used for the PAGE experiments to obtain an RNA con-
centration of 1.2 M. MgCl2 was added to a concentration of 3
mM. UV-monitored thermal denaturations and re-naturations
were replicated 10 times and monitored by measuring UV
absorbance (260 nm) using a Cary 3 spectrophotometer as pub-
lished (34, 35). The data points were averaged over 20 s and
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recorded with a temperature change of 1 °C per min from 4 to
90 °C. The one most inconsistent of the 10 melting transitions
(either a denaturation or renaturation) was discarded from
each set, and the resulting data were averaged on a point-by-
point basis.
For UV melts of the hmtRNAMet transcripts, the normal U8
and the 8U3C hmtRNAMet were dialyzed against water using
10-kDa cutoff dialysis cups (Stratagene). The U8 and 8U3C
hmtRNAMet transcripts were diluted to 0.5 M in a buffer con-
taining 10 mMNaCl and 10mMHepes-KOH, pH 8.0. The ther-
mal denaturation of the tRNAs was monitored by UV absorb-
ance at 260 nm using a Cary 3 spectrophotometer. Data points
were recorded once permin from 4 to 95 °Cwith a temperature
change of 1 °C per min. Following thermal renaturation, 6
mM Mg2 was added to the U8 and 8U3C transcripts, and




Previous studies (23) have shown that the transcript of mito-
chondrial tRNAMet has aminoacylation properties similar to
those observed with the native tRNA. Thus, it was possible to
use the normal transcript and a transcript containing the
8U3C mutation for studies on the effect of the mutation on
the properties of the tRNA. The 8U3C mutation leads to a
myopathy presumably arising from a reduction in translational
activity in mitochondria. To determine the biochemical conse-
quence of the 8U3C mutation, the abilities of the U8 and
8U3C hmtRNAMet transcripts to be aminoacylated by the
humanmitochondrialmethionyl-tRNA synthetase (hmMetRS)
were tested. Aminoacylation is an early step required for the
tRNA to be used in either the elongation or initiation phase of
protein synthesis and is thus of central importance for protein
synthesis in mitochondria. The normal U8 transcript was ami-
noacylated as expected (23); however, the 8U3C mutation
caused a significant reduction in the rate of aminoacylation of
the tRNAby hmMetRS (Fig. 1B). This observation provides one
clear rationale for the failure of this tRNA to function in mito-
chondrial protein biosynthesis.
Not unexpectedly, the normal hmtRNAMet was aminoacy-
lated by the E. coli MetRS (Fig. 1C). Interestingly, whereas the
8U3C hmtRNAMet was poorly aminoacylated by the
hmMetRS, it was not aminoacylated at all by the E. coliMetRS
(Fig. 1C) suggesting that the mutated tRNA had a significantly
altered structure. The hmMetRS is believed to be both struc-
turally and functionally homologous to its prokaryotic counter-
part (23). However, this work demonstrates that the hmMetRS
is less discriminatory than E. coliMetRS for the structure of the
tRNA. Because a major determinant in the recognition of
tRNAMet by the MetRS is thought to lie in the anticodon
sequence that is unchanged (36), theweak aminoacylationmost
likely reflects significant structural alterations in the tRNA as a
result of the mutation.
Formylation of Normal and 8U3C Mutated Met-tRNAMet—
The defective aminoacylation of the 8U3C hmtRNAMet made
it difficult to assess the effects of the mutation on additional
steps in protein biosynthesis. However, small amounts of the
aminoacylated 8U3Cmutated hmtRNAMet could be isolated,
permitting a limited investigation of additional steps in
translation.
In the mammalian mitochondrial system, the Met-tRNAMet
must be formylated by the mitochondrial transformylase
(MTFmt) to be used in initiation (19, 37). The abilities of the U8
and 8U3C Met-tRNAMet to be formylated were tested by
incubation of the [35S]Met-tRNAwith the bovineMTFmt in the
presence of folinic acid to provide the formyl group. The con-
version of [35S]Met to [35S]fMet wasmonitored by TLC (Fig. 2).
The normal hmtRNAMet formylates well, but interestingly,
formylation of the 8U3C mutated tRNA is barely detectable
(Fig. 2). The inability of the 8U3C mutated tRNA to be effi-
ciently aminoacylated and formylated suggests there would be
little fMet-tRNAMet available for initiation of protein synthesis.
Binding of Normal and 8U3C Mutated Met-tRNAMet to
EF-Tumt—The hmtRNAMet must be partitioned between the
initiation and elongation stages of protein synthesis. To func-
tion in elongation, the formylation step must be by-passed and
the Met-tRNAMet must form a ternary complex with EF-Tumt
(also known as mitochondrial EF1A). The binding of amino-
acyl-tRNA to EF-Tumt is normally studied at 0–4 °C to protect
the aminoacyl bond from hydrolysis (38, 39). Because the
strength of the interaction of Met-hmtRNAMet with EF-Tumt
had never been determined, these experiments were begun
with an investigation of the binding of EF-Tumt to the normal
Met-tRNAMet. Because the transcript begins with a 5-terminal
A rather than the G residue preferred by the T7 RNA polymer-
ase, the construct used for transcription contained a hammer-
head ribozyme and T7 promoter gene sequence upstream of
the tRNA sequence. Following transcription, the hammerhead
ribozyme was cleaved leaving behind a tRNA beginning with a
5-OH rather than the 5-phosphate normally present in
tRNAs. The presence of a 5-phosphate is not required for ami-
noacylation or formylation of this tRNA (data not shown). The
5'
3'
FIGURE 1. The sequence of the normal and 8U3C hmtRNAMet and the
effect of the mutation on the aminoacylation of the tRNA. A, primary
sequence of hmtRNAMet indicating the position of the 8U3C mutation. The
Sprinzl numbering system is used throughout (53). B, aminoacylation of the
normal (circles) and 8U3C (U8C) transcripts (squares) of hmtRNAMet by
hmMetRS. C, aminoacylation of normal (circles) and 8U3C (U8C) mutated
(squares) hmtRNAMet by E. coli MetRS.
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formation of the ternary complex with E. coli EF-Tu is not
affected by the 5-phosphate (40), but no studies were available
on the importance of this group for EF-Tumt. The first issue
addressed was whether the ability of EF-Tumt to bind the ami-
noacylated tRNA in the ternary complex was affected by the
presence of the 5-phosphate. For this experiment, the amino-
acylated transcript carrying the 5-OH was tested in ternary
complex formation and compared with an aminoacylated tran-
script that carried a 5-phosphate following phosphorylation by
polynucleotide kinase. As indicated in Fig. 3A, the Met-tRNA
transcript carrying the 5-phosphate formed a ternary complex
with EF-Tumt efficiently. However, the transcript with the
5-OH was noticeably less active in interacting with EF-Tumt.
This observation indicates that, unlike E. coli EF-Tu, the inter-
action of EF-Tumt with Met-tRNA benefits from contact with
the phosphate at the 5- end of the aminoacyl-tRNA. Examina-
tion of the residues in the binding pocket for the aminoacyl-
tRNA in the bacterial and mitochondrial factors reveals that
Glu-287 in E. coli EF-Tu is replaced by the oppositely charged
residue Arg-335 in EF-Tumt (27). This change alters the charge
balance in the region of EF-Tu in close proximity to the 5-end
of the tRNA in the ternary complex and may provide an addi-
tional stabilizing interaction enhancing the binding of EF-Tumt
to the conformationally fragile mitochondrial tRNAs.
Analysis of the binding curve betweenEF-Tumt and the phos-
phorylated Met-hmtRNAMet indicates a binding constant of
27  6 nM at 0 °C. This value is in good agreement with the Kd
value observed for the binding of several other mitochondrial
aminoacyl-tRNAs to EF-Tumt (41).
The interaction of the 8U3C Met-hmtRNAMet was then
investigated at 0 °C using the phosphorylated transcript (Fig.
3B). Rather surprisingly, the mutated tRNA was as effective as
the normal transcript in interacting with EF-Tumt under these
conditions suggesting that the 8U3CMet-tRNA had adopted
a tRNA-like conformation recognized by this factor. This
observation appeared to be in conflict with the poor activity of
the 8U3C hmtRNAMet in aminoacylation and formylation.
However, the previous assayswere carried out at 37 °C, whereas
the ternary complex assay was carried out at 0 °C. Hence, ter-
nary complex formationwas tested at 37 °Cwith both the phos-
phorylated U8 and 8U3C Met-hmtRNAMet species (Fig. 3C).
At this higher temperature, the 8U3C Met-hmtRNAMet was
almost inactive in ternary complex formation, whereas the U8
Met-hmtRNAMet had significant activity in ternary complex
formation. These data suggest a temperature-dependent desta-
bilization of the structure of the 8U3Cmutated tRNA. Struc-




FIGURE 2. Formylation of the normal and 8U3C mutated Met-
hmtRNAMet. A, conversion of the normal and 8U3C (U8C) mutated [35S]Met-
hmtRNAMet to [35S]fMet-hmtRNAMet as a function of time. The aminoacylated
tRNAs were incubated with bovine MTFmt for the indicated times. The amino
acid was hydrolyzed from the tRNA using alkali and the [35S]Met separated
from [35S]fMet by TLC. B, percentage of Met converted to fMet, over time, for
the normal (diamonds) and 8U3C (U8C) mutated (squares) hmtRNAMet.
FIGURE 3. Effect of the 8U3C mutation and the 5-phosphate on binding
of Met-hmtRNAMet to EF-Tumt at 0 and 37 °C. A, binding of normal Met-
tRNAMet with (diamonds) and without (squares) the 5-phosphate to EF-Tumt:
GTP. B, binding of EF-Tumt:GTP to normal (diamonds) and 8U3C (U8C)
mutated (squares) Met-tRNAMet at 0 °C, forming the ternary complex. C, ter-
nary complex formation for normal U8 (diamonds) and 8U3C (U8C) mutated
(squares) Met-tRNAMet at 37 °C.
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Chemical Probing of the Structure of the Normal U8 tRNAMet
in the Presence and Absence of Mg2—The structures of the
normal U8 and 8U3C mutant hmtRNAMet transcripts were
probed using SHAPE chemistry at 37 °C (24, 42). SHAPE chem-
istry relies on the differential reactivity of the nucleotide 2-OH
to the small molecule 1M7 (24, 42). Nucleotides in flexible,
single-stranded regions are preferentially modified by the rea-
gent, revealing different conformational states of residues
within the RNA. The chemically treated tRNA transcripts were
reverse-transcribed using a radiolabeled primer. Sites of modi-
ficationwere identified based on their ability to obstruct reverse
transcription. The cDNAproducts were analyzed on a denatur-
ing polyacrylamide gel. When residues in unstructured or flex-
ible regions of the tRNA aremodified, the reverse transcriptase
stops, leading to a labeled band observed on the gel one residue
shorter than the position of the modification. Comparison of
the position of these bands to a sequencing ladder allows the
identification of residues susceptible to modification (32). The
reactivity of each nucleotide toward 1M7 was quantified, and
the relative reactivity of each nucleotide was assigned a value
between 0 and 1. The higher the value, the greater the pro-
pensity the nucleotide has to be in an unstructured region.
This information allowed us to develop a model of the tRNA
structure (43).
The reactivity of 1M7 is not Mg2-sensitive; hence, SHAPE
chemistry was used to examine the influence of Mg2 on the
structure formed by the normal and 8U3C mutant
hmtRNAMet transcripts. In the presence of Mg2, a number of
distinct structural features were observed for the normal
hmtRNAMet (Fig. 4, A and B). The 2-OH of residues predicted
to form the acceptor stem and the D-stem were not accessible
to the reagent. This indicated that they were largely paired as
expected. Only a single residue in the D-loop was highly reac-
tive suggesting that most of the residues in this region of the
tRNA were involved in tertiary interactions that reduced their
reactivity. The anticodon stem was clearly protected, but as
expected residues in the anticodon loopwere available formod-
ification. The variable loop again showed limited modification
indicating tertiary interactions. These interactions were
expected to take place primarily with residues in the D-loop as
would be expected from tertiary contacts observed in canonical
tRNAs. The T-stem apparently formed despite the presence of
the U-U pairs. However, in contrast to other tRNAs (33), resi-
dues in the T-loop were quite reactive indicating that they were
accessible in the tertiary structure of this tRNA.
The folding of the hmtRNAMet structure required the pres-
ence ofMg2 (Fig. 4A, lanes 1 and 3 compared). Mg2 not only
stabilizes the negatively charged backbone but is known to bind
to specific sites of canonical cytoplasmic tRNAs to aid in folding
their tertiary structures. In the absence of Mg2, the
hmtRNAMet structure was open and highly reactive to 1M7,
indicating that both secondary and tertiary interactions had
been lost (Fig. 4A, lane 1).
A more thorough analysis of the SHAPE data through quan-
titation of the individual nucleotide reactivities provided addi-
tional insight into the three-dimensional structure formed by
the unusual hmtRNAMet. The SHAPE reactivity pattern was
suggestive of a folded cloverleaf-shaped tRNA and was similar
to the reaction pattern observed with other tRNAs (33) (Fig.
5A). Superimposition of the nucleotide reactivities on the
L-shaped tRNA structure (43) (Fig. 5B) provided additional
information about possible tertiary interactions within the
tRNA. For clarity, the nucleotides have been colored according
to their level of reactivity. As expected, the most reactive por-
tion of the tRNA was the anticodon loop. The reactivity data
support a structure in which many of the conserved canonical
tertiary interactions are preserved. For example, nucleotides
U8, A14, and A21 which, in canonical tRNAs form a triple base
FIGURE 4. Structural consequence of the 8U3C mutation in hmtRNAMet
and the effect of Mg2. A, gel image showing the reactivity of the U8
hmtRNAMet transcript to 1M7 at 37 °C. Reactions were performed in the pres-
ence and absence of Mg2, and control reactions were performed lacking
1M7. Dideoxy-NTP sequencing reactions were also performed, and the
results show the positions of the G and U residues obtained using ddCTP and
ddATP. The oligonucleotides in the gel bands are one nucleotide longer than
those in the corresponding bands in the reaction lanes. The reactivities of the
various tRNA loops are highlighted. The vertical line on the gel indicates the
nucleotides within the acceptor stem. Bands above the 5-end of the acceptor
stem correspond to the structure cassette (24). B, structure of the hmtRNAMet
transcript indicating structural regions of interest. The U8, which is changed
in the 8U3C tRNA, is shown in red. C, gel image showing the 1M7 reactivity of
the 8U3C hmtRNAMet in the presence (lane 4) and absence (lane 2) of Mg2
at 37 °C. The gel is annotated as in A above. D, unstructured form of the 8U3C
hmtRNAMet transcript in the presence of Mg2 with C8 shown in red.
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pair, were all modestly reactive or nonreactive in hmtRNAMet.
Other possible preserved tertiary interactions are shown in Fig.
5B and include the expected interaction between nucleotides in
the D-loop and the variable loop such as between A15 andU48.
Despite the likely presence of many conserved tertiary inter-
actions in hmtRNAMet, other interactions are probably not
occurring because of the shortened sequence of this tRNA. For
example, interactions between the D- and T-loops may be dif-
ferent from canonical tRNAs because the D-loop is short and
lacks the commonGG sequence, whereas the T-loop is only six
nucleotides instead of the universal seven nucleotides found in
classical tRNAs.These deviations fromclassical tRNAs indicate
that hmtRNAMet cannot have theG18-U55 andG19-C56 inter-
actions that normally stabilize the corner of the L-shaped struc-
ture (3). Also, A58 in the T-loop was not reactive, whereas its
expected partner U54 showed significant reactivity. This sug-
gests that the canonical tertiary interaction of U54 with A58
may not occur. The tertiary interactions occurring in the
T-loop of the hmtRNAMet may be significantly different from
that of the canonical cytoplasmic tRNAs.
Chemical Probing of the Structure of the 8U3C Mutated
tRNA in the Presence and Absence ofMg2—SHAPE analysis of
the 8U3C mutated hmtRNAMet carried out at 37 °C in the
presence of Mg2 indicated that all of the nucleotides in the
tRNA were susceptible to modification except the three G-C
pairs in the anticodon stem. The single nucleotide mutation
(8U3C) at the corner of the ac-
ceptor stem and D-stem of the
hmtRNAMet thus resulted in a dras-
tic loss of structure that is seen even
in the presence of Mg2 (Fig. 4C,
lane 3). The regions of the D-loop,
the variable loop, acceptor stem,
and T-stem all exhibited an
increased reactivity to the reagent
1M7. For example, all of the resi-
dues in the D-loop and most of the
residues in the variable loop were
now reactive. Furthermore, the res-
idues in the acceptor stem, which
were base-paired in the normal U8
tRNA, were reactive. These changes
indicated that the tertiary structure
and a large portion of the secondary
structure had been lost because of
the mutation. As expected, the
8U3C mutant hmtRNAMet had
essentially no structure in the
absence of Mg2, as was observed
for the normal hmtRNAMet (Fig.
4C, lane 1). Even the anticodon stem
had lost its base-paired structure.
Clearly, the folding of the mutated
tRNA was not responding to the
presence of Mg2 and thus may
have lost one or more Mg2-bind-
ing sites critical to the structure. It is
likely that the loss in structure
observed upon mutation of 8U3C results from a loss of stabi-
lizing tertiary interactions that were present in the normal
hmtRNAMet and that are dependent on the presence of Mg2.
It should be noted that, alternatively, the tRNA could be folding
into a dynamic mixture of transient conformations that do not
reflect the structure of the normal U8 hmtRNAMet.
Analysis of the 8U3C mutated tRNA clearly showed a glo-
bal increase in reactivity (Fig. 5, C and D). This increase was
seen in all of the stems except the anticodon stem suggesting a
loss of these secondary structural elements. Both the D- and
T-loops also significantly increased in reactivity, suggesting a
loss in stabilizing tertiary interactions. The variable loop, which
makes extensive tertiary interactions in the U8 hmtRNAMet,
became highly reactive in the 8U3C tRNA. Although the
mutated 8U3C residue itself showed only a slight increase in
reactivity, its tertiary interaction partners, A14 and A21,
became highly reactive suggesting that they were unable to
form the necessary stabilizing tertiary interactions in this
region of the tRNA. When these reactivities were superim-
posed on the L-shaped hmtRNAMet structure, it was clear that
changing the single U8 nucleotide to a C lead to a loss of both
secondary and tertiary interactions resulting in a tRNA thatwas
largely unstructured (Fig. 5D).
Stability of Normal and 8U3C Mutated hmtRNAMet in a
Mitochondrial Extract—A number of mutated mitochondrial
tRNAs are more rapidly degraded in vivo than are the normal
FIGURE 5. Tertiary interactions in the hmtRNAMet and the effect of mutating U8 to C on these interac-
tions. A, histogram showing the reactivity of nucleotides in the U8 hmtRNAMet transcript. Nucleotides with
high, medium, low, and no reactivity are shown in red, orange, green, and black, respectively (see “Experimental
Procedures”). Structural regions in the tRNA are shown above the histogram. The numbering shown is from the
Sprinzl system (53). B, L-shaped structure of hmtRNAMet. Possible tertiary interactions occurring in the tRNA are
shown and are based on conserved interactions that occur in the canonical cytoplasmic tRNAs. The nucleotides
are colored based on reactivity as in A above. C, reactivity of nucleotides in 8U3C hmtRNAMet. The histogram
is labeled and colored as in A above. D, unstructured form of the 8U3C mutated hmtRNAMet. The colors of the
nucleotides are based on their reactivity to 1M7 as in the histogram in C. In contrast to the reactivity of the
nucleotides of the normal U8 hmtRNAMet to 1M7, the reactivity data for the 8U3C mutant hmtRNAMet clearly
did not fit the L-shaped structure.
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tRNAs (43, 44). To determine how the 8U3Cmutation might
affect the stability of the tRNAwithinmitochondria, the degra-
dation of the normal and 8U3C mutated hmtRNAMet was
monitored in an extract prepared from the mitochondrial
matrix. For this analysis, the U8 and 8U3C transcripts were
labeled at the 5-end with 32P-phosphate and incubated with
varying concentrations of the mitochondrial extract. The
amount of the tRNA remaining intact was determined by pre-
cipitation with trichloroacetic acid. The 8U3Cmutated tRNA
wasmore readily degraded by themitochondrial nucleases than
the normal U8 tRNA (Fig. 6). When visualized on a sequencing
gel, it was apparent that the normal tRNA was degraded in
discrete locations corresponding to loops, whereas themutated
tRNAwas degraded throughout the body of the tRNA (data not
shown). The differential degradation of the two tRNAs was in
agreement with the SHAPE data showing an overall lack of
structure in the mutated tRNA. Furthermore, these data sug-
gested that, in addition to being incorrectly folded, themutated
tRNA will also be more rapidly degraded within the milieu of
the mitochondrial matrix.
Association of T-half-molecules with U8 and 8U3C
D-half-molecules—To further probe the effect of the 8U3C
mutation on the structure of the tRNA in the presence and
absence of Mg2, D- and T-domain hmtRNAMet half-mole-
cules were chemically synthesized with the two pseudouri-
dines, , and either U8 or 8U3C in the D-half-molecule
(Fig. 7A). Previously, we demonstrated that incubation of
the normal D- and T-half-molecules of bovine mtRNAMet in
the presence of Mg2 resulted in reconstitution of the
mtRNAMet (25). The reconstituted tRNA could be observed as
a slow moving band under native conditions. The effect of the
8U3Cmutation on the reconstitution of the humanmtRNAMet
was assessed using PAGE migration in the presence and
absence of Mg2.
In PAGE, when the slower migrating mtRNAMet D-half-
molecule containing the normal U8 was titrated with the
faster migrating T-half-molecule at 3 mM Mg2, a gel shift
was observed that corresponded to the formation of a com-
plex between the two half-molecules (Fig. 7C) (25). In fact,
two new bands attributed to the reconstituted tRNA
appeared to increase with increasing amounts of the T-half-
molecule. This increase was accompanied by the expected
decrease in the D-half-molecule (Fig. 7C). The two gel bands
attributed to the reconstituted mtRNAMet contained both
half-molecules, as determined by denaturing PAGE (data not
shown). The slower moving mtRNAMet (70% of the recon-
stituted tRNA) migrated in a fashion similar to that of E. coli
cytoplasmic tRNA (Fig. 7C), and to the migration found for
the complex of bovine mtRNAMet half-molecules (25). The
faster moving band representing some 30% of the reconsti-
tuted human mtRNAMet migrated faster than the D-half-
and slower than the T-half-molecule. It is believed to be
folded into a second, but non-native, conformation. In the
absence of Mg2, the migration of the D-half-molecule was
more rapid than in the presence of Mg2 suggesting a Mg2-
dependent conformational change in the half-molecule. In
the absence of Mg2, the two half-molecules could not form
a complex (Fig. 7, C and D).
The mutated 8U3C D-half- and normal T-half-molecules
were incapable of forming a complex either in the presence or
absence of Mg2 (Fig. 7, E, F, and B). The migration of the
mutant 8U3C D-half-molecule was much faster than that of
the normal D-half-molecule in the presence of Mg2, suggest-
ing a conformational difference in the half-molecule resulting
from the 8U3C change. In addition, the rapidmigration of the
8U3C D-half-molecule was not affected by Mg2. These
results suggested that the 8U3C D-half-molecule had lost the
ability to bind one or more structurally important Mg2
ions. The hmtRNAMet transcripts were subjected to gel elec-
trophoresis under native conditions and in the presence and
absence of Mg2 (data not shown). In the presence of Mg2,
the 8U3CmtRNAMet transcript migrated more slowly than
the normal transcript. In the absence of Mg2, only a slight
difference in migration was observed. These data again indi-
cated that the 8U3C and normal mtRNAMet responded dif-
ferently to Mg2.
Thermal Denaturation of the Mutated tRNA—The thermal
stabilities of the U8 and 8U3C D-half-molecules and the nor-
mal T-half-molecule were also determined in the presence
and absence of Mg2. The addition of counterions, particu-
larlyMg2, to RNA stabilizes its structure. The PAGE results
suggested that the 8U3C D-half-molecule had lost the abil-
ity to bind one or more critical Mg2. The U8 half-molecule
gave different melting profiles in the presence and absence of
Mg2 (Fig. 8A). In contrast, the 8U3C D-half-molecule had
the same thermal melting profile in both the presence and
absence of Mg2 (Fig. 8B) indicating that it was unable to
respond to the addition of this counterion. This observation
again argues that the mutation led to the loss of a Mg2-
binding site.
The normal T-half-molecule exhibited amajor thermal tran-
sition that was stabilized by the presence of Mg2 (Fig. 8C).
This was surprising considering that the T-stem contained two
adjacent U-U mismatches (Fig. 1A). However, tandem U-U
mismatches form one of the most stable internal loops in RNA
and, despite the stem distortion that results, their presence
actually stabilizes duplex RNA (45, 46).
Thermal denaturation of the intact U8 hmtRNAMet tran-
script demonstrated the importance of Mg2 for the correct
folding of hmtRNAMet. In the absence of Mg2, the U8 tRNA
FIGURE 6. Stability of the normal and 8U3C mutated hmtRNAMet in a
mitochondrial extract. The percentage of trichloroacetic acid-precipitable
counts for the normal U8 transcript (diamonds) and the 8U3C mutated
(squares) hmtRNAMet remaining after incubation of 32P-labeled transcripts
with increasing amounts of a mitochondrial matrix extract.
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began melting at low temperatures but demonstrated a major
transition at around 30 °C (Fig. 9A, blue). In the presence of
Mg2, the U8 tRNAwas stably folded until about 50 °Cwhere a
major transition occurred (Fig. 9A, pink). The shift in melting
temperature in the presence of Mg2 demonstrated that the
structure was stabilized by the presence of Mg2. Conversely,
melting the 8U3C hmtRNAMet transcript did not show a
strong dependence onMg2. In both the presence and absence
of Mg2, the 8U3C transcript failed to show a major thermal
transition, although significant hyperchromicity was observed
(Fig. 9B). Clearly themutant 8U3C
tRNA did not show the same struc-
tural response to Mg2 as did the
normal U8 tRNA. In addition, the
lack of a major thermal transition
for the 8U3C mutated tRNA
agrees with the results of the
SHAPE experiments, which indi-
cated that the 8U3C mutated
tRNA lacks significant structure.
DISCUSSION
Considerable information is now
available on the sequences of mam-
malian mitochondrial tRNAs. With
some exceptions, these tRNAs can
be drawn as cloverleaf structures
and are thought to be able to fold
into a three-dimensional structure
that resembles the classical L-shape
of canonical tRNAs (43). In mam-
mals, the mitochondrial tRNAs are
A/U-rich reflecting the base com-
position of the genomes. In general,
these tRNAs are shorter (71–72
nucleotides in length) than bacterial
or eukaryotic cytoplasmic tRNAs
(about 76 nucleotides for class I
tRNAs). The D-loop tends to be
smaller and most of them lack the
GG sequence that is involved in ter-
tiary interactions in normal tRNAs
(8). The T-loop varies from five to
nine residues deviating from the
highly conserved seven residues
found in cytoplasmic tRNAs. The
cryo-EM study on the structure of
the bovine mitochondrial ribosome
(47) shows a tRNA tightly bound at
the P-site. The structure of this
tRNA can be fit into the crystallo-
graphic structure of a cytoplasmic
tRNA except in the region of the
elbowperhaps reflecting the smaller
sizes of the T- and D-loops of many
mitochondrial tRNAs. The D- and
T-stems also vary significantly in
size and often contain mismatches.
Searches for tertiary interaction networks corresponding to
those found in other tRNAs have not been successful, and no
compensating set of interactions can be deduced from
sequence alignments (43). As discussed in more detail under
“Results,” our data indicate that hmtRNAMet forms a cloverleaf
structure but that D-loop and T-loop interactions cannot fol-
low the pattern observed in canonical tRNAs.
More than 130 pathogenic mutations (see MITOMAP avail-
able online) have been observed in mitochondrial tRNA genes
(48).Numerous studies have been carried out in efforts to delin-
FIGURE 7. Effect of Mg2 and the 8U3C (U8C) mutation on reconstitution of the hmtRNAMet from the
D-half- and T-half-molecules. A, D-half-molecule (A1–C32, pink) and T-half-molecule (A33–A76, blue) were
chemically synthesized to include 27 and 50. B, summary of the efficiency of reconstituting hmtRNA
Met from
the normal (purple) and mutated (green) D-half- and T-half-molecules in the presence of Mg2. C, titration of
the U8 D-half-molecule (D) with increasing concentrations of the T-half-molecule (T) at 3 mM Mg2 showing the
formation of two complexes (C1 and C2). D, titration of the U8 D-half-molecule with increasing concentrations
of the T-half-molecule in the absence of Mg2 showing that no complex is formed. E, titration of the 8U3C
D-half-molecule with increasing concentrations of the T-half-molecule at 3 mM Mg2 showing that little com-
plex is formed. F, titration of the 8U3C D-half-molecule with increasing concentrations of the T-half-molecule
in the absence of Mg2 showing that no complex is formed. The 1st lane labeled wt D/T is a positive control
showing the formation of the complex between the normal U8 D-half-molecule (37.6 M) and the normal
T-half-molecule (37.1 M). The lane labeled Dm indicates the migration of the 8U3C mutated D-half-molecule
alone, whereas the T lane indicates the migration of the normal T-half-molecule.
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eate the underlying causes for the defects observed in genetic
diseases arising from mutations in mitochondrial tRNA genes
(43). In many cases, numerous deleterious biochemical effects
are observed with the mutated tRNAs making it difficult to
assess the precise cause of the pathogenicity. There are several
examples in which structural perturbations are believed to
arise as a result of the mutations (14, 49). One of the more
complete studies recently published (50) examined muta-
tions in tRNATyr. These studies showed that mutation of
G15 and A22 in the D-loop as well as U54 in the T-loop
resulted in structural alterations in the mutated tRNAs.
These mutations are thought to disrupt tertiary interactions
and lead to the loss of aminoacylation of these tRNAs.
The data presented here indicate that the single point
mutation 8U3C in hmtRNAMet causes the loss of stable
structure at physiological temperatures. The inability of the
8U3C mutated tRNA to fold properly severely impedes amino-
acylation, formylation, and interaction with EF-Tumt. Conse-
quently, the mutated tRNA cannot function effectively in either
translational initiation or elongation. With a significant propor-
tion of the heterogeneous population of mitochondria having the
8U3C mutation, the result is the pathogenic manifestation of
disease.
ResidueU8plays an important role in forming and stabilizing
the tertiary structure of tRNA. Early work (51) indicated that
Mg2 also plays a critical role in stabilizing the structure of the
D-arm and its tertiary interactions. The crystal structure of
yeast tRNAPhe clearly shows that Mg2 is tightly and site-spe-
cifically coordinated in binding pockets formed by tertiary
interactions within the tRNA (52). It is believed that formation
of these binding pockets precedes Mg2 binding, and that the
subsequent binding of Mg2 then stabilizes the three-dimen-
sional architecture of the tRNA (52). A single tightly coordi-
natedMg2 is bound at the elbow of tRNAPhe. The binding site
for this ion is formed by nucleotides in the D-arm and at the
corner of the D-stem and acceptor stem (Fig. 10A). The phos-
phate of U8 contacts this Mg2 through a bridging water mol-
ecule. U8 is also involved in a triple non-Watson-Crick pairing
interaction with nucleotides A14 and A21 forming the binding
pocket (Fig. 10B). Interestingly, in canonical tRNAs, U8 is
highly conserved and is considered a universal nucleotide (Fig.
FIGURE 8. Effect of Mg2 on the thermal stabilities of the normal and
8U3C mutated hmtRNAMet D-half-molecules and the normal T-half-
molecule. Normal U8 (A), 8U3C (U8C) mutated D-half-molecules (B), and
normal T-half-molecule (C) were subjected repeatedly to thermal denatur-
ation and renaturation monitored at 260 nm. The average of nine melt pro-
files conducted on different days are plotted for each RNA in the absence
(blue) and presence (pink) of 3 mM Mg2.
FIGURE 9. Thermal denaturation of the U8 and 8U3C transcripts in the
presence and absence of Mg2. A, thermal denaturation of the U8 tran-
script was monitored at 260 nm in the absence (blue) and presence (pink)
of 6 mM Mg2. B, 8U3C (U8C) transcript in the absence (blue) and pres-
ence (pink) of 6 mM Mg2 was subjected to thermal denaturation moni-
tored at 260 nm.
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10C) underlying the critical role of this nucleotide in forming
the site-specific Mg2 binding pocket that leads to a correctly
folded, functionally L-shaped tRNA. Our work suggests that
mutation of this single nucleotide to cytosine (8U3C) in
hmtRNAMet prevents formation of this Mg2 binding pocket,
resulting in a tRNA that fails to fold in the presence ofMg2. The
loss of the structure of the tRNA could occur because of a disrup-
tion in the base pairing between nucleotides U8 and either A14 or
A21,which in turnwould destabilize the sharp turn and theMg2
binding pocket. Alternatively, loss of structure could result from
an inability to properly coordinate theMg2 ion via a water mol-
ecule in the pocket.Without the stabilizing effect ofMg2 bound
at this site, a drastic loss of structure results leading to a tRNA that
doesnot effectivelyparticipate inproteinbiosynthesis.Although it
is not possible to directly measure the specific binding of an indi-
vidual Mg2 ion, the data presented here are in agreement with
this basic hypothesis.
Of the 22 tRNAs present in humanmitochondria, 16 of them
have U at position 8 and 14 of them have the U8-A14-A21
combination seen in hmtRNAMet and canonical tRNAs. It is of
interest to note that the most common mutation in human
mitochondrial tRNAs (the A3243G mutation in the tRNALeu
gene associated withMELAS) is the mutation of A14 to G. The
extremely deleterious effect of this mutation is also likely to
arise from an inability to form the tertiary interaction involving
the U8-A14-A21 base triple and Mg2 coordination. The
absence of tertiary interactions between the D- and T-loop of
the hmtRNAMet suggests a substantial role for U8 and its asso-
ciated Mg2-binding site in stabilizing the three-dimensional
structure of the mitochondrial tRNA.
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